Literature DB >> 22329611

Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP).

James M Ritter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22329611      PMCID： PMC3370337          DOI： 10.1111/j.1365-2125.2012.04193.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  25 in total

Review 1.  The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology.

Authors:  W Haverkamp; G Breithardt; A J Camm; M J Janse; M R Rosen; C Antzelevitch; D Escande; M Franz; M Malik; A Moss; R Shah
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

2.  Timing of new black box warnings and withdrawals for prescription medications.

Authors:  Karen E Lasser; Paul D Allen; Steffie J Woolhandler; David U Himmelstein; Sidney M Wolfe; David H Bor
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

Review 3.  The significance of QT interval in drug development.

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

4.  Guide to Receptors and Channels (GRAC), 5th edition.

Authors:  Stephen P H Alexander; Alistair Mathie; John A Peters
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

5.  Comparison of the effects of levofloxacin on QT/QTc interval assessed in both healthy Japanese and Caucasian subjects (pages.

Authors:  Atsushi Sugiyama; Yuji Nakamura; Satomi Nishimura; Satomi Adachi-Akahane; Yuji Kumagai; Juleen Gayed; Asif Naseem; Georg Ferber; Jorg Taubel; John Camm
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

Review 6.  Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.

Authors:  Vaibhav Salvi; Dilip R Karnad; Gopi Krishna Panicker; Snehal Kothari
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

7.  Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome.

Authors:  Fadi G Akar; Gan-Xin Yan; Charles Antzelevitch; David S Rosenbaum
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

8.  [Ventricular tachycardia with 2 variable opposing foci].

Authors:  F Dessertenne
Journal:  Arch Mal Coeur Vaiss       Date:  1966-02

9.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

10.  Cisapride and ventricular arrhythmia.

Authors:  Sean Hennessy; Charles E Leonard; Craig Newcomb; Stephen E Kimmel; Warren B Bilker
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335
View more
  8 in total

1.  Factors to Consider in the Selection of Dopamine Agonists for Older Persons with Parkinson's Disease.

Authors:  Mark Dominic Latt; Simon Lewis; Olfat Zekry; Victor S C Fung
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

2.  The role of concentration--effect relationships in the QTc interval prolongation: case sotalol.

Authors:  Pertti J Neuvonen; Erkki Elonen
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

Review 3.  Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.

Authors:  G Gromo; J Mann; J D Fitzgerald
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

4.  Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data.

Authors:  Andreas D Meid; Anna von Medem; Dirk Heider; Jürgen-Bernhard Adler; Christian Günster; Hanna M Seidling; Renate Quinzler; Hans-Helmut König; Walter E Haefeli
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

5.  A meta-analysis on the cardiac safety profile of domperidone compared to metoclopramide.

Authors:  Serhat Bor; Mesut Demir; Oktay Ozdemir; Kivanc Yuksel
Journal:  United European Gastroenterol J       Date:  2018-09-10       Impact factor: 4.623

Review 6.  Cardiac Safety of Osimertinib: A Review of Data.

Authors:  Michael S Ewer; Sri Harsha Tekumalla; Andrew Walding; Kwame N Atuah
Journal:  J Clin Oncol       Date:  2020-12-23       Impact factor: 44.544

7.  Anesthesia in a patient with gitelman syndrome.

Authors:  Rajkiran Babubhai Shah; Veena R Shah; Geeta P Parikh; Kalpana S Vora
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Jul-Sep

Review 8.  PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia.

Authors:  Matthew K Ito; Raul D Santos
Journal:  J Clin Pharmacol       Date:  2016-06-21       Impact factor: 3.126
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.